Modulari-T
YC W23Montreal, CA · Founded 2021 · 4 employees · 3 known investors
Modulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.
BiotechDeep TechHealthtechMedical DevicesGene TherapyCell TherapySynthetic BiologyOncologyin /modulari-t-bio/@ycombinatorycombinator.com ↗
Founders & leadership· Y Combinator alumni (W23)
DW
David WhiteinFounder
SM
Stephanie MokinFounder
Investors · 3
In the news
- Modulari-T 🧬 Unleash the full power of the immune systemycombinator.com · 2023